Skip to main content
SpringerLink
Log in

The Association of Clinical Research Professionals 2012 Global Conference and Exhibition

14–17 April 2012; Houston, TX, USA

  • Meeting Report
  • Published:
Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Food and Drug Administration. Guidance for industry: oversight of clinical investigations. a risk-based approach to monitoring [online]. Available from URL: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM269919.pdf [Accessed 2012 May 17]

  2. Food and Drug Administration. Guidance for industry: determining the extent of safety data collection needed in late stage premarket and postapproval clinical investigations [online]. Available from URL: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM291158.pdf [Accessed 2012May 17]

  3. Koren MJ, Koski G, Reed DP, et al. APCR physician investigator competence statement. The Monitor 2011; 25 (4): 79–82

    Google Scholar 

  4. Food and Drug Administration. Code of Federal regulations title 21 food and drugs. Part 56: institutional review boards [online]. Available from URL: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=56.111 [Accessed 2012 May 29]

  5. US Department of Health and Human Services. Code of Federal regulations title 46 public welfare. Part 46: protection of human subjects [online]. Available from URL: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html [Accessed 2012 May 29]

  6. International Conference on Harmonisation. Good clinical practice (ICH E6). ICH Steering Committee, 1996 July [online]. Available from URL: http://ec.europa.eu/health/files/eudralex/vol-10/3cc1aen_en.pdf [Accessed 2012 May 29]

  7. Council for International Organizations of Medical Sciences. International ethical guidelines for biomedical research involving human subjects. Geneva: CIOMS, 2002

    Google Scholar 

  8. International Conference on Harmonisation. Guidance for industry: ICH topic E 11 clinical investigation of medicinal products in the paediatric population [online]. Available from URL: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E11/Step4/E11_Guideline.pdf [Accessed 2012 May 17]

  9. Food and Drug Administration. Guidance for industry: exposure-response relationships. Study design, data analysis, and regulatory applications [online]. Available from URL: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072109.pdf [Accessed 2012 May 17]

Download references

Acknowledgements

No funding was received for the preparation of this report. The author has no conflicts of interest that are directly relevant to the content of this report.

Author information

Authors and Affiliations

  1. Adis, Auckland, New Zealand

    Sue Pochon

Authors
  1. Sue Pochon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pochon, S. The Association of Clinical Research Professionals 2012 Global Conference and Exhibition. Pharm Med 26, 243–248 (2012). https://doi.org/10.1007/BF03262481

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03262481

Keywords

Search

Navigation